Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer

Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer

Liya Liu, Hao Yu, Lihong Huang, Fang Shao, Jianling Bai, Donghua Lou, Feng Chen Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China Background: The correlation between overall survival (OS) and progression...

Full description

Bibliographic Details
Main Authors:	Liu L, Yu H, Huang L, Shao F, Bai J, Lou D, Chen F
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-04-01
Series:	OncoTargets and Therapy
Online Access:	http://www.dovepress.com/progression-free-survival-as-a-surrogate-endpoint-for-overall-survival-peer-reviewed-article-OTT

Similar Items

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
by: Cicero G, et al.
Published: (2018-05-01)

Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology
by: Sherrill B, et al.
Published: (2012-10-01)

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer
by: Shuang Zhang, et al.
Published: (2021-07-01)

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
by: Wu-Hao Lin, et al.
Published: (2021-04-01)

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
by: Katrin M. Sjoquist, et al.
Published: (2018-08-01)

Progression-Free Survival Early Assessment is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
by: Giuseppe Cabibbo, et al.
Published: (2021-12-01)

Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
by: B. Marco, et al.
Published: (2020-10-01)

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer
by: Hideki Maeda, et al.
Published: (2021-06-01)

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
by: Beauchemin C, et al.
Published: (2014-06-01)

Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?
by: Forsythe A, et al.
Published: (2018-05-01)

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists
by: Bonnetain Franck, et al.
Published: (2010-06-01)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
by: Run-Cong Nie, et al.
Published: (2020-05-01)

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma
by: Run-Cong Nie, et al.
Published: (2020-06-01)

Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival
by: Sun L, et al.
Published: (2020-10-01)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
by: Hisao Imai, et al.
Published: (2015-01-01)

Surrogate Endpoints in Medicine
by: Sudhir Srivastava, et al.
Published: (2002-01-01)

Factors Affecting Mortality of Patients Survived from First Stroke---Is Recurrence an Only Surrogate Endpoint?
by: Yi-Ching Lai, et al.
Published: (2009)

PREDICTORS OF OVERALL SURVIVAL IN PATIENTS WITH RECURRENT NON-SEMINOMATOUS GERMINAL TESTICULAR TUMORS ON CURRENT SECOND-LINE CHEMOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2014-07-01)

PREDICTORS OF OVERALL SURVIVAL IN PATIENTS WITH RECURRENT NON-SEMINOMATOUS GERMINAL TESTICULAR TUMORS ON CURRENT SECOND-LINE CHEMOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2014-07-01)

Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
by: Forsythe A, et al.
Published: (2018-05-01)

Overall Survival Results with Surgical Treatment After Neoadjuvant Chemotherapy in Local Invasive Gastric Cancers
by: Gökhan Ertuğrul
Published: (2019-04-01)

CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
by: Yilin Tong, et al.
Published: (2021-01-01)

Statistical Analysis in Surrogate Endpoints
by: SU, TE-CHIH, et al.
Published: (1998)

A novel nomogram based on cardia invasion and chemotherapy to predict postoperative overall survival of gastric cancer patients
by: Hanjun Mo, et al.
Published: (2021-08-01)

Survival Outcomes Following Combination of First-Line Platinum-Based Chemotherapy with S-1 in Patients with Advanced Gastric Cancer
by: Anna Koumarianou, et al.
Published: (2020-12-01)

A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer
by: Bishal Gyawali, et al.
Published: (2021-02-01)

The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality of Life
Published: (2021-08-01)

Analysis of the Efficacy and Survival of Third-line Treatment  in Advanced Non-small Cell Lung Cancer
by: Lan SHAO, et al.
Published: (2012-06-01)

Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation
by: Kazuhiro Tanaka, et al.
Published: (2019-01-01)

Survival of an elderly patient with lung cancer treated with first-line chemotherapy
by: Oscar Augusto Quintana Blancos, et al.
Published: (2021-10-01)

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
by: Kasahara Norimitsu, et al.
Published: (2015-12-01)

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
by: Li X, et al.
Published: (2018-07-01)

Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer
by: Changyuan Meng, et al.
Published: (2020-01-01)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
by: John A. Wagner
Published: (2002-01-01)

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study
by: Marschner N, et al.
Published: (2015-04-01)

LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
by: Sumadi Lukman Anwar, et al.
Published: (2019-01-01)

Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition
by: Gilbert Peter B., et al.
Published: (2015-09-01)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
by: Yayi He, et al.
Published: (2021-02-01)

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis
by: Khader Shameer, et al.
Published: (2021-07-01)

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.
by: Shih-Hung Yang, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_1eggqm308tmie7sh9vml65e794